Publication | Open Access
Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset
132
Citations
16
References
2018
Year
OncologyClinical TrialsCare Egfr TkiEgfrm Advanced NsclcMedicineRadiation OncologyFlaura Asian SubsetHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1